The temporary reduction in blood volume during donation could theoretically increase hypoglycaemia risk in susceptible individuals, so donors taking sulfonylureas should monitor their glucose levels carefully on donation day
Interestingly, the Rybelsus label advises physicians to monitor kidney function in patients who experience serious vomiting
IGFBP-3 is the major carrier protein for circulating IGF-1, and suppression has implications for endogenous IGF-1 bioavailability post-cycle
A targeted add-on for plateaus and stalled progress Low-Dose Naltrexone Oral Tablet Starting at $119 /month Starting at $129 /month GLP-1 medications work powerfully for most people, but some hit a wall
Effective management of bloating can make treatment with semaglutide more comfortable and sustainable over the long term
In clinical studies, participants taking Retatrutide experienced up to 24% weight loss over 48 weeks, more than observed with current GLP-1 treatments